Greg is an executive level contributor for startups to Fortune 500 software, biotech, and healthcare companies. He has over thirty-five years of diverse experience including oversight of finance and accounting, mergers and acquisitions, business development, software development and operations, biotech manufacturing and research, and sales and marketing. He has strong process development and improvement experience, complex business intelligence analytics knowledge, and is capable of building and running highly effective and efficient teams.
Prior to joining CFO Selections, Greg was the Executive Vice President and a member of the Board of Directors for Genelex Corporation, a genetic laboratory servicing the healthcare industry that developed and marketed a related software decision support tool. Prior to his tenure at Genelex, he served on the Board of Directors and as Co-Managing Director of BioXcelerator Corporation, and as the CEO of Invizeon Corporation.
Greg holds an MBA in Finance and Marketing from the University of Oregon, in addition to two Bachelors of Science degrees in Microbiology and Immunology, as well as Food Science and Technology.